Clinical Trials Arena December 10, 2024
The UK is seeing an overall improvement in its desirability as a clinical trials location, but it still has ground to make up.
The UK’s desirability as a clinical trial location is improving, reversing its previously downward trajectory, according to the Association of the British Pharmaceutical Industry (ABPI).
The UK was fourth in the world for the number of Phase III trials hosted in 2017 but had dropped to tenth by 2021. In its annual report on the UK’s clinical trial scene, the ABPI found that the UK has now improved to take the eighth spot but remains below other European locations, including Spain (third), Germany (sixth) and Italy (seventh).
It has also seen improvement in its popularity as a...
Today's Sponsors
Today's Sponsor